focus -WSS

focus

author：comprehensive 2025-09-29 22:45:59 - browse：98

Launching your first clinical trial is the type of announcement most biotech executives eagerly anticipate, hoping to celebrate with employees. But for Celsius Therapeutics CEO Tariq Kassum, it’s proving to be more difficult than he anticipated.

That’s because in recent days, Celsius, based in Cambridge, Mass., has been forced to conduct a round of layoffs, sources told STAT. Kassum confirmed around 75% of Celsius’ 40-person team had been laid off, and disclosed that the biotech has also been quietly paring back its pipeline this year. It shut down almost all early-stage research projects, including pausing all of its cancer drug work, in order to conserve enough cash for the Phase 1 trial it announced this week.

“It’s an incredibly bittersweet moment.… The cognitive dissonance there is just really, really hard,” Kassum told STAT. “But I do think that you’re seeing a lot of other companies doing what we are, which is, as painful as it is, to focus on the nearest term value drivers, the things that can get to patients the quickest, and make the painful decisions that allow you to live to fight another day.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Verily hires former Apple Health leader as chief scientific officer

explore

WSS

Bill would allow buprenorphine prescription for addiction via telehealth

Biden calls for immediate release of Niger's president amid apparent coup

Biden calls for immediate release of Niger's president amid apparent coup

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

Infant mortality in U.S. rose last year for first time in decades: CDC

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

hotspot

focus

focus

Bright Health sells Medicare Advantage business to Molina

Life sciences investors close nearly $6 billion in new funds

Guidelines to prevent youth baseball injuries need more muscle

Brain injuries and the importance of a second opinion

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Infant mortality in U.S. rose last year for first time in decades: CDC

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

How neuroscience research could help beat back brain cancer

United colonoscopy coverage change 'may cost lives,' doctors say

Explaining an after

leisure time

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

2 US Navy sailors arrested for allegedly spying for China

Influencer to be charged after chaos erupts in New York City's Union Square

My superpower is killing ticks

What the cancer research community can learn from the Covid response

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

hotspot

explore

knowledge

focus